CD52, Human (Tarextumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD52, Human (Tarextumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD52, Human (Tarextumab biosimilar)
CloneTarextumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA, FCM
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD52 Recombinant Antibody (Tarextumab). Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In January 2015, the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results.
Immunogenn/a
Other NamesAnti-CD52 Recombinant Antibody, Research Grade Tarextumab, Anti-Human CD52 Recombinant Antibody(Tarextumab), OMP-59R5, Antibody Drug Analogues, Monoclonal Antibody, YR1312, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1359940-55-8
Catalog #YR1312
Priceplease inquire
Order / More InfoCD52, Human (Tarextumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.